400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2020-06-04
神经退行性疾病治疗用新药研发商
医药研发/制造
化学&生物药
Logos Capital;
Logos Capital;
Franklin Templeton Investments;
Franklin Templeton Investments;
Perceptive Advisors;
RTW Investments;
Sofinnova Partners;
LifeSci Venture Partners;
Suzanne Kayne;
Highside Capital Management;
Avidity Partners;
Janus Henderson Investors;
Viking Global Investors;
Sahsen Ventures;
Rick;
Rock Springs Capital;
Surveyor Capital;
Venrock Capital
动脉网-最新2026-06-10
求实药社2026-06-10
中国经营报2026-06-10
功能与专用化学品2026-06-10
中国医药报2026-06-10
动脉网-最新2026-06-10
中国农业科学院2026-06-10
药融圈info2026-06-10
精准药物2026-06-10
医药观澜2026-06-10